Related Experiment Video

Updated: May 26, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis

Mario Cazzola1, Sreedhar Anapurapu, Clive P Page

  • 1Department of Internal Medicine, Unit of Respiratory Clinical Pharmacology, University of Rome Tor Vergata, Rome, Italy. mario.cazzola@uniroma2.it

Pulmonary Pharmacology & Therapeutics
|December 14, 2011
PubMed
Abstract

Insights

Polyvalent Mechanical Bacterial Lysate (PMBL) significantly reduces respiratory tract infections in adults and children. This bacterial lysate therapy offers a promising approach to preventing common infections, with a low number needed to treat.

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Respiratory tract infections (RTIs) are a significant global health burden, causing morbidity, mortality, and economic costs.
  • Bacterial lysates, like Polyvalent Mechanical Bacterial Lysate (PMBL), are explored to enhance innate immune defenses against RTIs.
  • PMBL is derived from common respiratory pathogens using mechanical lysis.

Purpose of the Study:

  • To evaluate the efficacy of PMBL in preventing respiratory tract infections.
  • To synthesize evidence from randomized controlled trials comparing PMBL to placebo or no treatment.

Main Methods:

  • A meta-analysis of randomized clinical trials (RCTs) was conducted.
  • The primary outcome was the prevention of acute respiratory tract infections or exacerbations.
  • Relative risk (RR) and number needed to treat for one to benefit (NNTB) were calculated.

Main Results:

  • Data from 15 RCTs involving 2557 patients showed PMBL significantly reduced infections compared to placebo (RR -0.513).
  • The number needed to treat for one to benefit (NNTB) was 1.15, indicating high efficacy.
  • Consistent benefits were observed across various patient groups, including children and those with recurrent infections, COPD, or tuberculosis.

Conclusions:

  • PMBL demonstrates effectiveness in preventing respiratory tract infections in both children and adults.
  • While a trend towards clinical significance was noted in COPD patients, further research with larger sample sizes is needed to achieve statistical significance.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...